These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 25126138)

  • 1. Pattern and quality of scientific communications on drug safety produced by a regional pharmacovigilance center in Nepal.
    Palaian S; Ibrahim MI; Mishra P
    Pharm Pract (Granada); 2010 Jul; 8(3):179-86. PubMed ID: 25126138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bibliometric analysis of adverse drug reactions and pharmacovigilance research activities in Nepal.
    Shrestha S; Danekhu K; Kc B; Palaian S; Ibrahim MIM
    Ther Adv Drug Saf; 2020; 11():2042098620922480. PubMed ID: 32587678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
    Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
    Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse drug reaction reporting in a pharmacovigilance centre of Nepal.
    Jha N; Shankar PR; Bajracharya O; Gurung SB; Singh KK
    Australas Med J; 2012; 5(5):268-71. PubMed ID: 22848322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidelines for submitting adverse event reports for publication.
    Kelly WN; Arellano FM; Barnes J; Bergman U; Edwards RI; Fernandez AM; Freedman SB; Goldsmith DI; Huang KA; Jones JK; McLeay R; Moore N; Stather RH; Trenque T; Troutman WG; van Puijenbroek E; Williams F; Wise RP; ;
    Drug Saf; 2007; 30(5):367-73. PubMed ID: 17472416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring drug safety in Astrakhan, Russia.
    Kirilochev OO; Dorfman IP; Umerova AR
    Int J Risk Saf Med; 2015; 27 Suppl 1():S33-4. PubMed ID: 26639700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signals of adverse drug reactions communicated by pharmacovigilance stakeholders: protocol for a scoping review of the global literature.
    Sartori D; Aronson JK; Onakpoya IJ
    Syst Rev; 2020 Aug; 9(1):180. PubMed ID: 32791982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Completeness of published case reports on suspected adverse drug reactions: evaluation of 100 reports from a company safety database.
    Impicciatore P; Mucci M
    Drug Saf; 2010 Sep; 33(9):765-73. PubMed ID: 20701409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines for submitting adverse event reports for publication.
    Kelly W; Arellano F; Barnes J; Bergman U; Edwards R; Fernandez A; Freedman S; Goldsmith D; Huang K; Jones J; McLeay R; Moore N; Stather R; Trenque T; Troutman W; van Puijenbroek E; Williams F; Wise R; ;
    Therapie; 2009; 64(4):289-94. PubMed ID: 19804709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidelines for submitting adverse event reports for publication.
    Kelly WN; Arellano FM; Barnes J; Bergman U; Edwards IR; Fernandez AM; Freedman SB; Goldsmith DI; Huang K; Jones JK; McLeay R; Moore N; Stather RH; Trenque T; Troutman WG; van Puijenbroek E; Williams F; Wise RP; ;
    Pharmacoepidemiol Drug Saf; 2007 May; 16(5):581-7. PubMed ID: 17471601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Online reporting of adverse drug reactions: a study from a French regional pharmacovigilance center.
    Abadie D; Chebane L; Bert M; Durrieu G; Montastruc JL
    Therapie; 2014; 69(5):395-400. PubMed ID: 25269141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic adverse drug reactions: a preliminary report from the regional pharmacovigilance center, western Nepal.
    P S; P M; Pr S
    Pak J Pharm Sci; 2008 Oct; 21(4):465-7. PubMed ID: 18930872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pattern of adverse drug reactions reported by the community pharmacists in Nepal.
    Palaian S; Ibrahim MI; Mishra P
    Pharm Pract (Granada); 2010 Jul; 8(3):201-7. PubMed ID: 25126141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre.
    Watson S; Chandler RE; Taavola H; Härmark L; Grundmark B; Zekarias A; Star K; van Hunsel F
    Drug Saf; 2018 Feb; 41(2):203-212. PubMed ID: 28933055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attitudes among healthcare professionals to the reporting of adverse drug reactions in Nepal.
    Santosh KC; Tragulpiankit P; Gorsanan S; Edwards IR
    BMC Pharmacol Toxicol; 2013 Mar; 14():16. PubMed ID: 23497690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of completeness of suspected adverse drug reaction reports submitted to the mexican national pharmacovigilance centre: a cross-sectional period-prevalence study.
    Sánchez-Sánchez B; Altagracia-Martínez M; Kravzov-Jinich J; Moreno-Bonett C; Vázquez-Moreno E; Martínez-Núñez JM
    Drug Saf; 2012 Oct; 35(10):837-44. PubMed ID: 22924896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does spontaneous adverse drug reactions' reporting differ between different reporters? A study in Toulouse Pharmacovigilance Centre.
    Nicol C; Moulis F; Bondon-Guitton E; Durrieu G; Montastruc JL; Bagheri H
    Therapie; 2019 Oct; 74(5):521-525. PubMed ID: 31029402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The nature of the scientific evidence leading to drug withdrawals for pharmacovigilance reasons in France.
    Olivier P; Montastruc JL
    Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):808-12. PubMed ID: 16700082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse drug reactions in Nigerian children: a retrospective review of reports submitted to the Nigerian Pharmacovigilance Centre from 2005 to 2012.
    Obebi Cliff-Eribo K; Sammons H; Star K; Ralph Edwards I; Osakwe A; Choonara I
    Paediatr Int Child Health; 2016 Nov; 36(4):300-304. PubMed ID: 26384567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of a changed legislation on reporting of adverse drug reactions in Sweden, with focus on nurses' reporting.
    Karlsson SA; Jacobsson I; Boman MD; Hakkarainen KM; Lövborg H; Hägg S; Jönsson AK
    Eur J Clin Pharmacol; 2015 May; 71(5):631-6. PubMed ID: 25845655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.